Cronos Group's earnings call highlighted strong revenue growth and market leadership in both domestic and international markets, notably in Israel. The company has a solid balance sheet and is undertaking strategic expansions to address supply constraints. However, challenges include potential tariffs in Israel and temporary supply constraints affecting growth. Despite these challenges, the positive aspects largely outweigh the negatives.

Company Guidance -

Q2 2025

In the 2025 first quarter earnings call, Cronos Group provided several key metrics and guidance for the fiscal year. The company's net revenue was reported at $32.3 million, marking a 28% increase from the previous year, with their adjusted gross margin improving to 44%. The Spinach brand secured a 4.6% market share in Canada, while the SOURZ by Spinach line held a 23% share in the gummy category. The Lord Jones brand maintained a 30.1% market share in the hash-infused pre-roll segment. Internationally, the Peace Naturals brand was the top flower brand in Israel with over 20% market share. Cronos announced a $50 million share repurchase program, maintaining a strong balance sheet with $838 million in cash and no debt. The company anticipates their GrowCo expansion to alleviate current supply constraints, aiming to bolster market share and operational efficiencies moving forward.

Strong Revenue Growth

Cronos reported consolidated net revenue of $32.3 million, a 28% increase from the prior year period, with constant currency net revenue growth at 33% year-over-year.

Market Leadership in Canada

The Spinach brand holds the second most popular brand position in Canada with 4.6% market share. In edibles, it maintains the number one position with 20.7% market share.

International Expansion Success

Cronos Israel grew revenue by over 40% year-over-year, with Israeli sales contributing nearly 30% of consolidated net revenue. Peace Naturals brand ended as the number one flower brand in Israel.

Improved Gross Margins

The adjusted gross margin improved significantly to 44% in Q1 2025, compared to 18% in Q1 2024.

Strong Balance Sheet

Cronos maintains a strong balance sheet with $838 million in cash and equivalents, and announced a $50 million share repurchase program.

Cronos Group (CRON) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CRON Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 07, 2025	2025 (Q2)	0.02 / -	-0.02	―	―	―
May 08, 2025	2025 (Q1)	0.01 / 0.02	-0.01	300.00% (+0.03)	―
Feb 27, 2025	2024 (Q4)	0.00 / 0.11	-0.12	191.67% (+0.23)	―
Nov 12, 2024	2024 (Q3)	<0.01 / 0.02	0	―	―
Aug 08, 2024	2024 (Q2)	>-0.01 / -0.02	-0.01	-100.00% (-0.01)	―
May 09, 2024	2024 (Q1)	-0.01 / -0.01	-0.05	80.00% (+0.04)	―
Feb 29, 2024	2023 (Q4)	-0.04 / -0.12	-0.21	42.86% (+0.09)	―
Nov 08, 2023	2023 (Q3)	-0.02 / 0.00	-0.1	―	―
Aug 08, 2023	2023 (Q2)	-0.03 / -0.01	-0.05	80.00% (+0.04)	―
May 09, 2023	2023 (Q1)	-0.04 / -0.05	-0.09	44.44% (+0.04)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CRON Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 08, 2025	$1.85	$2.00	+8.11%
Feb 27, 2025	$1.85	$2.00	+8.11%
Nov 12, 2024	$1.97	$2.26	+14.72%
Aug 08, 2024	$2.22	$2.32	+4.50%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.